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Abstract  
 
  Trigonella foenum-graecum (TFG) is one of medicinal plants contains some steroidal 
sapogenin such as diosgenin, yamogenin, gitogenin, tigogenin and trigoneoside, also alkaloid 
trigonellin, which is have many activity as antidiabetic, estrogenic and also as anti cancer. This 
experiment was done to explore the activity of some extract of TFG on some cell lines such as 
MCF7 (Human Breast Cancer Cell-line), T47D (Human Breast Cancer Cell-line), PC3 (Human 
Prostate Cell-line) and SKOV (Human Ovarian Carcinoma Cell-line). This assay was done using 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium) methods. Results showed that ethyl 
acetate fraction gives the lowest IC50 than another extracts. IC50 for PC3 is 66.24 ppm, IC50 
for MCF7 is 41.81 ppm, IC50 for T47D is 58.63 ppm. These datas can be used for further 
research to isolate the active compound from TFG. 
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INTRODUCTION 
 
Fenugreek seed or Foenigraeci semen is 
dried seed from Trigonella foenum-graecum L., 
Leguminosae, (Anonim, 1979).Geographical 
distribution of Fenugreek is indigenous to the 
Mediterranean region, China, India and Indonesia. 
Fenugreek contains alkaloids (trigonelline, an 
alkaloid pyridine, gentianin and karpain), 
flavonoids e.g. vitexin in glycoside or ester 
form,isovitexin, orientin, vicenin, quercetin and 
luteolin, some sapogenin steroid ingredients, e.g. 
diosgenin, precursor for sexual hormone (Evans, 
2002), its isomer Yamogenin (Dewick, 1997), 
gitogenin, tigogenin, and trigoneoside (saponine 
like estrogen) which have effect as phytoestrogen 
for menopause symptoms therapy.Fenugreek 
contains diosgenin in base free form 0.8 – 2.2 %. 
Fenugreek also contains fatty oil 20-30%, essential 
oil, saponine, nicotinamide, choline, bitter 
compound and mucilage (Evans, 2002). 
Empirically fenugreek was use as aphrodisiac, 
carminative, diuretic, emmenagogue, emollient, 
galactogogue and tonic. Many researches, 
preclinically and clinically, showed that fenugreek 
have activity for diabetic disease (Annida and 
Stanley 2004).Fenugreek also have estrogenic 
effect, as Phytoestrogen, predicted by its sapogenin 
steroid contains (Agustini, 2007). It can induce 
uterine contraction, so it should be avoided during 
pregnancy. Phytoestrogen is used as alternative for 
Hormone Replacement Therapy (HRT) to help 
reducing menopause symptoms. It can be used for 
long term until the body can make adaptation on 
the new level hormone (Badziad, 2003). 
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Figure 1. Some chemicals contains of Trigonella foenum-graecum L. Diosgenin (A), Yamogenin (B), 
Protodioscin (C), and Tigogenin (D). 
Medicinal plants have been widely used for 
cancer treatment both as prevention and treatment. 
In contrast to cancer treatment using synthetic drug 
that can be given as a primary drug or as an 
additional therapy (adjuvant), treatment with 
medicines derived from plants can also be intended 
for prevention (chemopreventive). The aim of 
treatment is approximately similar by synthetic 
drugs such as chemotherapy; immunotherapy or 
palliative therapies and cancer pain, in practice, 
always use the combination therapy treatment of 
several kinds of medicinal plants by also predicting 
the side effects that may occur (Ma’at, 2003). 
Cancer is a malignant neoplasm and a 
growing network of small pieces that become large 
and unmanageable. To date approximately 120 
types of cancer are known and classified in 12 
major parts, namely: uterine cancer, breast, 
respiratory system, digestive organs, bones and 
muscles, urinary tract, skin, lymph, blood, eyes, 
gastrointestinal tract and nervous system (Saputra 
et al., 2000). Cancer treatment is medically 
requiring a very high cost. Clinically, the common 
cancer treatments are surgery, radiation and 
chemotherapy. In addition to these conventional 
treatments, also develop treatment using natural 
ingredients. 
Screening for anticancer from medicinal 
plants has already done for many years ago in 
many research institute in the world, and 
sometimes it takes a long time research. 
Meanwhile, many medicinal plants which 
empirically has been used but have no scientific 
data. Cytotoxicity test using human or animal cell-
lines are often used as a preliminary test in order to 
search for new cancer drugs. Antiviral and 
anticancer drug is a compound inhibiting cell 
growth without damaging the normal cells. 
According to the definition of National Cancer 
Institute (NCI) cytotoxicity test is only a test of 
toxicity to cells (tumors) in the media. Screen of 
the next antitumor or antineoplastic should be done 
by in vivo experiment. The term of anti cancer can 
be used when the results of clinical trials in human 
already done (Scheuer, 1987). 
Refer to data that showed TFG having 
estrogenic activity as phytoestrogen, inspiring to 
study its possibility as Selective Estrogen Receptor 
Modulators (SERMs) candidate. SERMs such as 
tamoxifen, which are used clinically for the 
treatment of breast cancer, act as estrogen agonists 
in certain tissues but exhibit antiestrogenic effects 
in others (Rosenbaum and Osborne, 2000). There 
are several researches about SERMs candidates for 
post tumor surgery therapy from phytoestrogen 
pure compounds, such as dammarane, a 
sapogenine steroid from ginseng (Oh et al., 1999), 
Genistein (an isoflavone from soybean) and 
resveratrol, a stilbene from grape (Baht et al., 
2001).   
 
MATERIALS AND METHODS 
 
Samples Preparation 
TFG seeds were obtained from 
Tawangmangu, Central Java, Indonesia. Seeds 
were dried and grind, then were extracted with 
methanol and ethanol. The methanolic extract was 
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fractioned with nhexane, ethylacetic (EtOAc) and 
n-buthanol. Every extract and fraction was dried 
with vacuum rotary evaporator. 
 
Cell Culture 
The cell lines PC3 (Human Prostate 
Cancer), SKOV3 (Human Ovarian Carcinoma), 
MCF-7 (Human Breast Adenocarcinoma), T47D 
(Human Breast Cancer) were obtained from 
Laboratory for Development of Industrial Agro 
and Biomedical Technology (LAPTIAB-BPPT) 
Indonesia. Cells were routinely maintained and 
grown in 75 cm2 flasks at 370 C, 5% CO2 and in a 
95% humidified atmosphere. The growth medium 
was prepared as following : RPMI 1640,Gibco life 
Technologies with phenol red and 2 mM 
glutamine, 100 U/ml penicillin, 0.1 mg/ml 
Streptomycin, 1 mM sodium pyruvate and 
supplemented with 10% Foetal Bovine Serum 
(FBS, Gibco Life Technologies) which already 
heat inactivated at 560 C for 30 min. Passaging of 
cells was carried out using 4 ml of trypsin-EDTA 
at room temperature for 75 cm2 flask, respectively 
for 3 min. After that, 10 ml media with 10% FBS 
were used to reduce the action of trypsin on cells. 
After centrifugation, the obtained cells were 
platted. 
 
Cytotoxicity Test with MTT Method 
Cells were platted into 96-well plates 
(10,000 cells/well) in medium RPMI with phenol 
red containing 10% Fetal Bovine Serum (FBS), 
100U/ml penicillin, 0.1 mg/ml streptomycin and 
1mM sodium pyruvate, then incubated for 24 hours 
at 370 C, 5% CO2 and in a 95% humidified 
atmosphere. After 24 hours, medium was changed 
with samples (extracts and phases of TFG) in 
growth medium in different concentration and 
incubated for another 24 hours at 370 C, 5% CO2 
and in a 95% humidified atmosphere. Assays were 
done in wide range concentration, from 10 ppm 
until 500 ppm, divide into six variation 
concentration. 
After 24 hours treatment, the cells were 
washed with Phosphate Buffer Saline (PBS).Then 
the MTT (3-(4,5- Dimethylthiazol-2-yl)-2,5 
Diphenyltetrazolium) solution in medium, was 
added followed by incubation for 4 hours 
at 370 C, 5% CO2 and in a 95% humidified 
atmosphere. The crystal of formazan blue will be 
formed. After that, reaction was stopped by added 
Sodium Dodecyl Sulphate (SDS) into every well. 
Leave plate in dark place for 12 hours (overnight). 
The intensity of the color formed was measured by 
ELISA reader at 570nm. 
 
RESULTS AND DISCUSSION 
 
Results of percentage growth of SKOV 
cells, MCF7 cells, T47D cells and PC3 cells were 
performed in table I – table IV and Fig. 2-5. Each 
data was presented from 6 (six) concentration 
variation, with n=3. 
 
 
 
Table I. Percentage growth of Trigonella foenum-graecum on SKOV3 cells (n=3) 
 
Concentration 
(ppm) 
% Growth SKOV3 cells 
EtOH extr. MetOH extr. EtOAc Phase 
10 106.36 96.87 102.80 
20 106.64 96.17 96.28 
50 89.97 77.08 96.33 
10 97.09 53.31 96.87 
250 42.50 20.44 28.53 
500 12.24 12.24 12.89 
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Figure  2. Effect of TFG on growth of SKOV3 cells. The results were plotted as percent of SKOV3 growth 
(relative cell growth (%)) versus concentration part permillion (ppm) (n=3) 
 
Table II. Percentage growth of Trigonella foenum-graecum on MCF7 cells (n=3) 
 
Concentration 
   (ppm) 
% Growth MCF7 cells 
MetOH 
extr. 
EtOH 
extr. 
EtOAc 
Phase 
Hexan 
Phase 
BuOH 
Phase 
Water 
Phase 
10 110.61 116.21 78.72 75.17 107.74 100.89 
20 111.21 111.33 78.54 92.71 97.80 107.95 
50 98.67 119.53 30.20 82.82 73.13 102.25 
10 46.65 67.57 19.47 46.90 32.25 100.05 
250 18.57 18.63 17.96 18.99 20.54 92.21 
500 17.06 17.60 17.90 18.87 18.82 73.34 
 
 
 
Figure  3. Effect of TFG on growth of MCF7 cells. The results were plotted as percent of MCF7 growth 
(relative cell growth (%)) versus concentration part permillion (ppm) (n=3) 
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Table III. Percentage growth of Trigonella foenum graecum on T47D cells (n=3) 
 
Concentration 
   (ppm) 
% Growth T47D cells 
MetOH extr. EtOH extr. EtOAc Phase 
Hexan 
Phase 
10 102.28 112.25 88.42 96.75 
20 68.69 68.27 90.92 98.94 
50 92.78 78.58 33.50 111.20 
10 55.81 54.25 17.28 30.21 
250 16.69 16.73 16.65 16.35 
500 15.72 16.05 16.86 16.69 
 
 
 
Figure  4. Effect of TFG on growth of T47D cells. The results were plotted as percent of T47D growth 
(relative cell growth (%)) versus concentration part permillion (ppm) 
 
 
Table IV. Percentage growth of Trigonella foenum graecum on PC3 cells (n=3) 
Concentration 
(ppm) 
% Growth PC3 cells 
EtOH extr. MetOH extr. EtOAc Phase 
10 93.44 87.79 75.39 
20 93.93 80.20 70.65 
50 61.66 89.15 59.65 
10 57.41 59.04 58.02 
250 16.15 14.60 20.48 
500 16.27 14.52 15.05 
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Figure  5. Effect of TFG on growth of PC3 cells. The results were plotted as percent of PC3 growth (relative 
cell growth (%)) versus concentration part permillion (ppm) 
  
Table V. IC50 value from some extracts and phases of TFG on PC3, SKOV3, MCF7 and T47D cell-lines. 
Each data was obtained from six variation concentration with n=3 
No. Cell-line Samples of TFG IC50(ppm) 
1. 
PC-3 
EtOH Extract 101.52 
2. MetOH Extract 99.05 
3. EtOAc Phase 66.24 
4. 
SKOV3 
EtOH Extract 230.92 
5. MetOH Extract 116.48 
6. EtOAc Phase 208.74 
7. 
MCF7 
MetOH Extract 186.09 
8. EtOH Extract 241.24 
9. EtOAc Phase 41.81 
10 Hexane Phase 102.11 
11. BuOH Phase 136.25 
12. Water Phase 1569.26 
13. 
T47D 
MetOH Extract 140.31 
14. EtOH Extract 128.37 
15. EtOAc Phase 58.63 
16. Hexane Phase 206.60 
 
Recent studies suggest that TFG and its 
active compounds may possess anticarcinogenic 
potential. Raju et al. (2004) showed that diosgenin, 
a steroid saponin from TFG can inhibit 
azoxymethane-induced aberrant crypt foci 
formation in F344 rats and induces apoptosis in 
HT-29 human colon cancer cells. Also refer from 
Agustini et al. (2007) that showed that TFG have 
estrogenic effect on ovariectomized and immature 
rats.  Some phytoestrogens are believed to have 
selective estrogen receptor modulator (SERM) 
activity with no action in the uterus but beneficial 
effects in the hypothalamus/pituitary unit and in 
the bone and are presently the focus of clinical 
interest (Wuttke et al., 2003). So it is an interesting 
phenomena to investigate and screen TFG potency 
on some cancer cell line, especially cell line with 
estrogen receptor positive. 
Cell lines used in this assay are PC3, 
SKOV3, MCF7 and T47D which are having 
hormonal receptor positive. MCF7 and T47D are 
cell lines from human breast cancer that have 
estrogen receptor positive. SKOV3 is human 
ovarian cancer cell lines which is also having 
estrogen receptor positive. PC3 is  human prostate 
cancer cell-lines with androgen hormone receptor 
positive. Their activity on cell-lines presented by 
Agustini, et al., 2011 
Indones. J. Cancer Chemoprevent., 2(2), 234-241 
 
240 
 
IC50 value, which is means the effective 
dose/concentration to inhibit 50% of cell growth. 
On PC3 cells, ethyl acetate phase of TFG 
could inhibit growth of cell more effective (IC50 = 
66.24 ppm) comparing with methanolic and 
ethanolic extract. Prostate cancer is a form of 
cancer that develops in the prostate, a gland in the 
male reproductive system. Most prostate cancer are 
slow growing, however, there are cases of 
aggressive prostate cancers. 
On breast cancer cell-line, MCF7 and T47D, 
also the most effective phase/extract is ethyl 
acetate phase of TFG with IC50 41.81ppm (on 
MCF7) and IC50 58.63 ppm (on T47D). Breast 
cancer (malignant breast neoplasm) is cancer 
originating from breast tissue, most commonly 
from the inner lining of milk ducts or the lobules 
that supply the ducts with milk. Cancer originating 
from ducts is known as ductal carcinomas those 
originating from lobules are known as lobular 
carcinomas. Nowadays, breast cancer treatment, 
especially with estrogen receptor positive, 
commonly use tamoxifen, one of SERM group. 
But the risk of taking this medicine in long time is 
also high. Many research were done to search 
another substance in this group, especially from 
phytoestrogen, which is have estrogenic effect, but 
effective to treat breast cancer with estrogen 
receptor positive. Interestingly, Asian women who 
consume a soy-rich diet (the most famous 
phytoestrogen) have about a 6-fold lower risk of 
developing breast cancer than their Western 
counterparts (Key et al., 1990), and population-
based studies have suggested that consumption of a 
phytoestrogen-rich diet is protective against 
prostate and bowel cancer, as well as 
cardiovascular disease. Hence, it is possible that 
these phytoestrogens function as chemopreventive 
agents. 
         On ovarian cells, methanolic extract of TFG 
more active than ethanolic extract and its 
ethylacetate phase. Ovarian cancer is the cancer 
that forms in tissues of the ovary (one of a pair 
female reproductive glands in which the ova, or 
egg, are formed). Most ovarian cancers are either 
ovarian epithelial carcinomas (cancer that begins in 
the cells on the surface of the ovary) or malignant 
germ cell tumors (cancer that begins in egg cells). 
         Predicted substances of TFG that have 
estrogenic effect are some sapogenin steroids, such 
as diosgenin, tigogenin and gitogenin. These 
substances could bind with estrogen receptor in the 
cells and compete the inner body estrogen to 
induce the proliferation.SERM works by blocks 
estrogen action in breast cell, but can activate 
estrogen’s action in other normal cells, such as 
bone, liver and uterine cells. These data can be 
used for further investigation to screen the most 
active substance of TFG, to find new SERM from 
phytoestrogen. 
 
CONCLUSION 
 
Results showed that ethyl acetate fraction 
gives the lowest IC50 than another extracts. IC50 
for PC3 is 66.24 ppm, IC50 for MCF7 is 41.81 
ppm, IC50 for T47D is 58.63 ppm. These datas can 
be used for further research to isolate the active 
compound from TFG. 
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